Successful treatment of pembrolizumab-induced acute kidney injury and severe eruptive skin lesions

Asian J Surg. 2024 Nov 16:S1015-9584(24)02343-1. doi: 10.1016/j.asjsur.2024.10.034. Online ahead of print.

Authors

Wenli Zou¹, Baihui Xu¹, Bin Zhu¹, Xiujun Xiu²

Affiliations

¹ Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
² Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: [email protected].

PMID: 39551630
DOI: 10.1016/j.asjsur.2024.10.034

No abstract available

Keywords: Acute kidney injury(AKI); Immune checkpoint inhibitor(ICI); Immune-related adverse events(irAE); Skin lesions.

Publication types

Letter